Suad Alsoghayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Suad Alsoghayer has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Alkhenizan
Department of Family Medicine and Polyclinics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
2 shared publications - Jamil Abudaia
Alfaisal University, College of Medicine, Riyadh, Saudi Arabia
1 shared publication - Kossay Elabd
Family Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU
1 shared publication Lama AlFakhri
King Saud University Medical City, Department of Emergency Medicine, Riyadh, Saudi Arabia
1 shared publication- Muath A. Alammar
Family Medicine, Shaqra Collage of Medicine, Shaqra University, Shaqra, Saudi Arabia
1 shared publication - Muath Alsaidan
Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 1 April 2021
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 14, 1663-1667
Incidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia
Background: Diabetes mellitus is prevalent in Saudi Arabia. Our study aims to estimate the rate and time of developing macrovascular and microvascular complications in diabetic patients in a primary care setting. Methodology: This is a retrospective cohort study. All collected data were retrieved using medical files and the electronic patient records of all diabetics having regular follow-ups in Family Medicine clinics, King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia, from the beginning of January 2002 to the end of December 2018. The data included the demographics of patients diagnosed with diabetes mellitus, their HbA1c, and the follow-up duration of the development of complications, which included cardiovascular complications and diabetic nephropathy. Results: We included 365 patients, of whom 47.1% males and 52.9% were females. The mean age of diabetes mellitus diagnosis in our population was 50 years (SD± 11.3). The mean duration of follow-up was 7.14 years (SD± 3.9). The rate of developing cardiovascular complications and diabetic nephropathy was 11.2% and 10.4%, respectively. The mean time to develop cardiovascular complications and diabetic nephropathy was 6 (SD± 3.9) and 5.24 (SD± 3.2) years, respectively. The mean time to develop the first diabetes complication was 5.5 years (SD± 3.6). There was no statistical significance in the mean of HbA1c between patients who developed diabetic complications and those who did not. Conclusion: Diabetes complications are common in the Saudi community. The duration of the development of cardiovascular complications and diabetic nephropathy was shorter than that indicated in international and national reports. Robust screening programs to diagnose and improve the control of diabetes mellitus should be established in the Kingdom.
- 1 April 2021
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 14, 1663-1667
Open AccessIncidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia
Background: Diabetes mellitus is prevalent in Saudi Arabia. Our study aims to estimate the rate and time of developing macrovascular and microvascular complications in diabetic patients in a primary care setting. Methodology: This is a retrospective cohort study. All collected data were retrieved using medical files and the electronic patient records of all diabetics having regular follow-ups in Family Medicine clinics, King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia, from the beginning of January 2002 to the end of December 2018. The data included the demographics of patients diagnosed with diabetes mellitus, their HbA1c, and the follow-up duration of the development of complications, which included cardiovascular complications and diabetic nephropathy. Results: We included 365 patients, of whom 47.1% males and 52.9% were females. The mean age of diabetes mellitus diagnosis in our population was 50 years (SD± 11.3). The mean duration of follow-up was 7.14 years (SD± 3.9). The rate of developing cardiovascular complications and diabetic nephropathy was 11.2% and 10.4%, respectively. The mean time to develop cardiovascular complications and diabetic nephropathy was 6 (SD± 3.9) and 5.24 (SD± 3.2) years, respectively. The mean time to develop the first diabetes complication was 5.5 years (SD± 3.6). There was no statistical significance in the mean of HbA1c between patients who developed diabetic complications and those who did not. Conclusion: Diabetes complications are common in the Saudi community. The duration of the development of cardiovascular complications and diabetic nephropathy was shorter than that indicated in international and national reports. Robust screening programs to diagnose and improve the control of diabetes mellitus should be established in the Kingdom.
- Open Access
- 1 July 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 2515-2520
Diagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study
Background: Obesity is a risk factor that leads to many chronic diseases and, unfortunately, its prevalence in Saudi Arabia is on the rise. To successfully manage obesity and its complications, patient must be accurately diagnosed. This study aims to investigate the diagnostic accuracy of body mass index (BMI) when diagnosing obesity within the Saudi population using body fat percentage (BF%) as the gold standard. Materials and Methods: This is a cross-sectional study that includes a calculated sample size of 942 subjects. Subjects were recruited from family medicine clinics that were linked to King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, Saudi Arabia from January 2005 to March 2016. BF% was estimated using DEXA scan. The diagnostic accuracy of BMI was assessed by using the WHO and the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) reference standard for obesity of BF% > 25% in men and > 35% for women. Results: Findings indicate, out of the study population, 29% of men and 53% of women are obese using BMI-defined obesity cut-off point 30 kg/m2. The prevalence of obesity was 83.9% and 97.3% in men and women, respectively, using BF%-defined obesity, which corresponds to BMI cut-off of 24 kg/m2. Even when considering the highest acceptable BF% based on the mean age of our participants (33% for men and 43% for women), the BMI cut-off to diagnose obesity should not exceed 27 kg/m2 among men and women in Saudi Arabia. Conclusion: The accuracy of BMI 30 kg/m2 to diagnose obesity among the Saudi population is limited. We have to lower the BMI cut-off point to improve its sensitivity as a screening tool for obesity. Our study suggests that the BMI cut-off point among Saudis and possibly the Arab population should not exceed 27 kg/m2 for both sexes.
- 1 July 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 2515-2520
Open AccessDiagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study
Background: Obesity is a risk factor that leads to many chronic diseases and, unfortunately, its prevalence in Saudi Arabia is on the rise. To successfully manage obesity and its complications, patient must be accurately diagnosed. This study aims to investigate the diagnostic accuracy of body mass index (BMI) when diagnosing obesity within the Saudi population using body fat percentage (BF%) as the gold standard. Materials and Methods: This is a cross-sectional study that includes a calculated sample size of 942 subjects. Subjects were recruited from family medicine clinics that were linked to King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, Saudi Arabia from January 2005 to March 2016. BF% was estimated using DEXA scan. The diagnostic accuracy of BMI was assessed by using the WHO and the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) reference standard for obesity of BF% > 25% in men and > 35% for women. Results: Findings indicate, out of the study population, 29% of men and 53% of women are obese using BMI-defined obesity cut-off point 30 kg/m2. The prevalence of obesity was 83.9% and 97.3% in men and women, respectively, using BF%-defined obesity, which corresponds to BMI cut-off of 24 kg/m2. Even when considering the highest acceptable BF% based on the mean age of our participants (33% for men and 43% for women), the BMI cut-off to diagnose obesity should not exceed 27 kg/m2 among men and women in Saudi Arabia. Conclusion: The accuracy of BMI 30 kg/m2 to diagnose obesity among the Saudi population is limited. We have to lower the BMI cut-off point to improve its sensitivity as a screening tool for obesity. Our study suggests that the BMI cut-off point among Saudis and possibly the Arab population should not exceed 27 kg/m2 for both sexes.